genetic screening

Oncology

Functional cancer profiling is an important step forward in the progress of oncology treatment, with the potential to transform patient outcomes.

News

The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.